Fig. 2

Kaplan–Meier estimation curves of cumulative events incidence during follow-up for the retinopathy outcome (a), for the composite renal outcome (b), for renal function deterioration (c), and for new microalbuminuria development (d), in patients divided according to tertiles of 24-month systolic blood pressure visit-to-visit variability (standard deviation)